author-photo

Maria Ornella Nicoletto

71

Papers

2520

Citations

Citation Trend

Filter By

Papers (50) Sort By

Journal Conference Others

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correlation of longtime efficacy maintenance PARP inhibitor therapy with pre-treatment in a single-institution experience.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (5)
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer

2019 Cell Death and Disease
Show All
- Source
- Cite
- Save
Citations (21)
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

2019 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (54)
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial

2018 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (72)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (788)
Health-related quality of life (HRQOL) and patient-centred outcomes with olaparib maintenance post-chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

2017
Show All
- Source
- Cite
- Save
Citations (0)
Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (16)